This inventor holds 1 USPTO granted patent. Top assignee: Zhejiang Hisun Pharmaceutical Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: The Innovations of Mingxiao Chen
Introduction
Mingxiao Chen is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative research and development efforts. His work focuses on therapeutic agents that have the potential to impact various medical conditions.
Latest Patents
Mingxiao Chen holds a patent for a cyano-substituted heteroarylpyrimidinone derivative. This invention includes a preparation method and its use as a therapeutic agent, specifically as an acetyl-CoA carboxylase (ACC) inhibitor. The details of the substituents in the formula are clearly defined in the patent description, showcasing the complexity and potential applications of his work.
Career Highlights
Mingxiao Chen is associated with Zhejiang Hisun Pharmaceutical Co., Ltd., where he continues to advance his research. His career is marked by a commitment to developing innovative solutions in the pharmaceutical industry. His contributions have been recognized within the scientific community, reflecting his dedication to improving health outcomes.
Collaborations
Mingxiao Chen has worked alongside talented colleagues such as Hejun Lv and Dongliang Guan. Their collaborative efforts have further enhanced the research environment and fostered innovation within their projects.
Conclusion
Mingxiao Chen's work exemplifies the spirit of innovation in the pharmaceutical field. His patent and ongoing research contribute to the development of new therapeutic agents that hold promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile